UK Syringe Market Size, Share, Opportunities, And Trends By Type (Insulin Syringe, Conventional Syringe), By Material (Glass, Plastic, Stainless Steel), By Syringe Size (Smaller Volume Syringe, Larger Volume Syringe) - Forecasts From 2023 To 2028

The Syringe is a cylindrical medical tool used to inject a solution into a human body. The syringe market is a key element of the pharmaceutical industry. Historically, syringes were only manufactured using glass or stainless steel. However, with the spread of awareness about the spread of infections and diseases due to reusable syringes, disposable syringes came to rise. Since then, the UK Syringe market has witnessed an increase in demand as new syringes and needles are needed after every injection to stick with the safety measures and precautions established by the National Medical Board. The growing population and the developments in the healthcare industry have opened up opportunities for more sales of medical devices like syringes.

Market Drivers

• Increasing need for vaccines and medicines

The increasing need for vaccines and medicines due to the emergence of new diseases and epidemics/pandemics is a leading factor in the upward trend of the UK Syringe market. For instance, the situation of COVID-19 led to a dramatic increase in the demand for vaccines designed to fight against the Corona Virus. The growing need for vaccines and injectables into the human body propelled the need to produce syringes to be used as a medium for the injection. Further, after the initial dose, the demand for syringes remained high for booster doses. Other than this, in absence of pandemics, syringes remain in high demand because syringes are the most used medical tools. For example, a diabetic patient might be prescribed insulin injections to keep the blood sugar levels in check. According to World Bank statistics, the number of people between the age group of 20 to 79 years suffering from diabetes increased from 5.2% to 6.3% in the United Kingdom, showing that the need for insulin syringes will increase in the coming years. In addition to this, there are several vaccinations given to infants and injections offered to patients to target the diseases they are fighting against.

Use as a blood-extracting and anesthesia-injecting tool

Syringes are used in labs, diagnostic centers, and clinics as a medium to extract blood from humans to conduct tests on the blood extracted. As per World Data Bank, the population in the UK has increased from 65 million in 2010 to 67.3 million in 2023. The increasing population needs increasing medical care and attention, creating more demand for medicines and medical tools like syringes. In addition to this, one of the methods used to administer anesthesia is the use of syringes. Usually, for cesarean operations opted for as an alternative to natural childbirth practices, local anesthesia is injected through syringes. According to the UK Government, 25% of births happen via cesarean. This shows that the demand for syringes is likely to rise gradually. Therefore, all these factors contribute to the steady growth of the UK syringe market.

Key Developments

• The UK Government announced its new strategy to invest around 10 billion pounds to provide the best medical equipment from syringes to diagnostic machines in February 2023. This decision was taken as a result of unrest in the medical labor union post the pressures in the medical work field since the COVID-19 situation.
• In August 2020, UK Government placed an order for 65 million syringes with Becton Dickinson Company to provide all UK citizens with better access to COVID-19 Vaccinations. BD innovated a novel model of syringes which minimizes the amount of waste which could help the Government in providing more vaccinations to its citizens.

However, the emergence of alternatives to syringes like insulin pens and needle-free injectors could be a restraining factor for the growth of the UK Syringes market. The UK syringes market is currently facing strong competition from new technological innovations like Insulin pens that are used to inject insulin into a diabetic patient without the use of a syringe. Other than the insulin pens, biotechnological companies are continuously striving to innovate new products leading to creations like needle-free injectors which can be used without syringes. Since these products are relatively new to the market, a large fragment of the customer base in the UK is skeptical of their use. Owing to this, the UK Syringes market can be expected to experience steadiness for the next few years.

UK Syringe Market Scope:

Key Market Segments:

• By Type
  • Insulin Syringe
  • Conventional Syringe
    • Eccentric Tip Syringe
    • Catheter Tip Syringe
    • Luer Lock Syringe
• By Material
  • Glass
  • Plastic
  • Stainless Steel
• By Syringe Size
  • Smaller Volume Syringe
  • Larger Volume Syringe

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY  

2.1. Research Data

2.2. Assumptions

3. EXECUTIVE SUMMARY

3.1. Research Highlights

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Force Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

5. UNITED KINGDOM SYRINGE MARKET, BY TYPE

5.1. Introduction

5.2. Insulin Syringe

5.3. Conventional Syringe

5.3.1. Eccentric Tip Syringe

5.3.2. Catheter Tip Syringe

5.3.3. Luer Lock Syringe

6. UNITED KINGDOM SYRINGE MARKET, BY MATERIAL

6.1. Introduction

6.2. Glass

6.3. Plastic

6.4. Stainless Steel

7. UNITED KINGDOM SYRINGE MARKET, BY SYRINGE SIZE

7.1. Introduction

7.2. Smaller Volume Syringe

7.3. Larger Volume Syringe

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

8.1. Major Players and Strategy Analysis

8.2. Emerging Players and Market Lucrativeness

8.3. Mergers, Acquisitions, Agreements, and Collaborations

8.4. Vendor Competitiveness Matrix

9. COMPANY PROFILES

9.1. BD

9.2. B. Braun Melsungen

9.3. Terumo Europe NV

9.4. Teleflex Incorporated

9.5. Nipro

9.6. ICU Medical, Inc.

9.7. Cardinal Health

9.8. 3M

BD

B. Braun Melsungen

Terumo Europe NV

Teleflex Incorporated

Nipro

ICU Medical, Inc.

Cardinal Health

3M